Centene Corporation (LON:0HVB)
62.00
+3.04 (5.16%)
At close: Apr 23, 2025
Centene Revenue
In the year 2024, Centene had annual revenue of $147.17B USD with 4.09% growth. Centene had revenue of $36.64B in the quarter ending December 31, 2024, with 2.34% growth.
Revenue
$147.17B
Revenue Growth
+4.09%
P/S Ratio
0.20
Revenue / Employee
$2.43M
Employees
60,500
Market Cap
23.20B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 147.17B | 5.78B | 4.09% |
Dec 31, 2023 | 141.39B | 5.39B | 3.97% |
Dec 31, 2022 | 136.00B | 17.43B | 14.70% |
Dec 31, 2021 | 118.57B | 14.29B | 13.71% |
Dec 31, 2020 | 104.28B | 33.47B | 47.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Centene News
- 13 days ago - Which Stocks Stayed Green as the Market Plummeted? - Kiplinger
- 14 days ago - Centene subsidiary awarded Nevada medicaid contract - Seeking Alpha
- 14 days ago - CENTENE SUBSIDIARY SILVERSUMMIT HEALTHPLAN AWARDED NEVADA MEDICAID CONTRACT - PRNewsWire
- 14 days ago - Health Net and Centene Foundation Invest More than $9 Million in Initiatives to Expand and Strengthen California's Physician Workforce - PRNewsWire
- 15 days ago - These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside. - Market Watch
- 16 days ago - Centene upgraded at Jefferies on favorable Medicaid updates - Seeking Alpha
- 16 days ago - This Centene Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday - Benzinga
- 21 days ago - Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath - Market Watch